Trials / Unknown
UnknownNCT01800981
Functionality Assessments in Patients (Adults and Children) Following Treatment With Debrase Compared to Standard of Care
Functionality Assessments in Patients (Adults and Children) Following Treatment With Debrase Compared to Standard of Care (SOC) Protocol MW2012-12-12
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 53 (estimated)
- Sponsor
- MediWound Ltd · Industry
- Sex
- All
- Age
- 10 Years – 61 Years
- Healthy volunteers
- Not accepted
Summary
Once the victim survived the acute phase, the outcome of wound healing, the scarring, became a major medical issue with complications that may lead to cosmetic and functional sequelae. Scar tissue is clinically distinguished from normal skin by an aberrant color, rough surface texture, increased thickness (hypertrophy), contraction, firmness and sometimes, decrease function. Thus, functional and cosmetic outcomes became at least important as wound closure in assessing wound healing products
Detailed description
This is a multi-center, assessor-blinded study aiming to evaluate the long term functionality in adults and children who have participated in study MW2004-11-02 (previous phase 3 study). We had previously shown that by using the MVSS scale which includes objective assessment of the physical characteristics of size, shape, volume, color, texture, and pliability as well as structural, mechanical and physiologic characteristics, lower (favorable) scores in Debrase vs. SOC group were observed in sub-groups of highly functional body parts of the hands and feet. This study will include specific functionality evaluation using the "Lower Extremity Functional Scale" test for burns in the lower extremities and the "QuickDASH" outcome measure for burns in the upper extremities as well as range of motion measurements of the joints (knee, ankle, shoulder, elbow and wrist, as relevant).
Conditions
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2013-07-01
- First posted
- 2013-02-28
- Last updated
- 2013-02-28
Locations
1 site across 1 country: Slovakia
Source: ClinicalTrials.gov record NCT01800981. Inclusion in this directory is not an endorsement.